Double-blind randomized trial of aflibercept versus placebo with docetaxel and prednisone for treatment of metastatic castration-resistant prostate cancer (mCRPC)

Skoneczna, Iwona Anna; Tannock, Ian; Fizazi, Karim; Ivanov, Sergey; Thellenberg-Karlsson, Camilla; Flechon, Aude; Orlandi, Francisco Jorquera; Gravis, Gwenaelle; Matveev, Vsevolod; Bavbek, Sevil E.; Gil, Thierry; Viana, Luciano S.; Aren, Osvaldo; Karyakin, Oleg; Elliott, Tony; Birtle, Alison J.; Magherini, Emmanuelle; Petrylak, Daniel Peter; Tombal, Bertrand; Rosenthal, Mark

dc.contributor.author	Skoneczna, Iwona Anna
dc.contributor.author	Tannock, Ian
dc.contributor.author	Fizazi, Karim
dc.contributor.author	Ivanov, Sergey
dc.contributor.author	Thellenberg-Karlsson, Camilla
dc.contributor.author	Flechon, Aude
dc.contributor.author	Orlandi, Francisco Jorquera
dc.contributor.author	Gravis, Gwenaelle
dc.contributor.author	Matveev, Vsevolod
dc.contributor.author	Bavbek, Sevil E.
dc.contributor.author	Gil, Thierry
dc.contributor.author	Viana, Luciano S.
dc.contributor.author	Aren, Osvaldo
dc.contributor.author	Karyakin, Oleg
dc.contributor.author	Elliott, Tony
dc.contributor.author	Birtle, Alison J.
dc.contributor.author	Magherini, Emmanuelle
dc.contributor.author	Petrylak, Daniel Peter
dc.contributor.author	Tombal, Bertrand
dc.contributor.author	Rosenthal, Mark
dc.date.accessioned	2021-03-02T22:47:43Z
dc.date.available	2021-03-02T22:47:43Z
dc.identifier.citation	Tannock I., Fizazi K., Ivanov S., Thellenberg-Karlsson C., Flechon A., Skoneczna I. A. , Orlandi F. J. , Gravis G., Matveev V., Bavbek S. E. , et al., "Double-blind randomized trial of aflibercept versus placebo with docetaxel and prednisone for treatment of metastatic castration-resistant prostate cancer (mCRPC)", 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31
dc.identifier.other	vv_1032021
dc.identifier.other	av_0ec6bdd6-feb8-4966-9c34-c2b5682d50be
dc.identifier.uri	http://hdl.handle.net/20.500.12627/15468
dc.language.iso	eng
dc.subject	İç Hastalıkları
dc.subject	ONKOLOJİ
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	Onkoloji
dc.title	Double-blind randomized trial of aflibercept versus placebo with docetaxel and prednisone for treatment of metastatic castration-resistant prostate cancer (mCRPC)
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	31
dc.contributor.firstauthorID	141678

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Bildiri [64839]

Basit öğe kaydını göster